Podcast

A Pragmatic Approach to Psychedelic Drug Development

In this episode, Brandon Li sits down with Srinivas Rao, Co-CEO of atai Life Sciences, for a deep dive into the pragmatic strategies shaping the future of psychedelic therapies. Srini shares how his background in engineering and neuropharmacology has info

Key topics include:

The evolution of atai Life Sciences, from a fund to a biotech company.
Innovative drug delivery approaches, like DMT oral thin films, and why simplicity and scalability matter.
Balancing diverse compounds and therapeutic areas with a focused portfolio strategy.
Advancing research in areas like social anxiety disorder and cognitive impairment in schizophrenia.
Tackling clinical trial challenges, including the placebo effect and trial design complexities.

Tune in to hear how a pragmatic lens is redefining what’s possible in neuropsychiatric drug development.

Subscribe and watch the full episode right here 👇

How inaccurate PTSD self-reporting can screen out 15% of qualified MDD patients

💡Our data suggests that a small gap in how some sites screen for PTSD history could be costing MDD trials as much as 15% of otherwise viable screening appointments. Read on to learn why. It’s an exciting time in MDD research. At Power, we’ve worked on over 50%

Four Site Archetypes Predict Recruitment Capacity. But Most Forecasts Treat Them the Same Way.

“Site archetype” tells us how many referrals to initially send to a site. How a site actually acts on its first two months of referrals tells us how to update.

When Competing Trials Start Eating Your Enrollment

Not every enrollment slowdown is a site problem. Sometimes it's a portfolio problem. Here's how to tell the difference and what to do about it.

Turning Pain Into Progress

How Sonia Prashar Built a Mission Around Mental Health

Read more

How inaccurate PTSD self-reporting can screen out 15% of qualified MDD patients

Four Site Archetypes Predict Recruitment Capacity. But Most Forecasts Treat Them the Same Way.

When Competing Trials Start Eating Your Enrollment

Turning Pain Into Progress